Literature DB >> 21690288

In vitro evaluation of the type of interaction obtained by the combination of terbinafine and itraconazole, voriconazole, or amphotericin B against dematiaceous molds.

Fernanda Simas Corrêa Biancalana1, Luzia Lyra, Angélica Zaninelli Schreiber.   

Abstract

In vitro associations using the checkerboard microdilution method indicated lower MIC ranges and MIC median values for each drug (terbinafine, itraconazole, voriconazole, and amphotericin B) in association than those obtained for each single drug. Fractional inhibitory concentration index (FIC) results showed 100% synergism in the association of terbinafine with voriconazole, 96.5% in the association of terbinafine with amphotericin B, and 75.9% in the association of terbinafine with itraconazole. Drug combinations may be useful for treatment of dematiaceous mold infections as an alternative treatment to enhance the effectiveness of each drug.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21690288      PMCID: PMC3165310          DOI: 10.1128/AAC.01015-10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  23 in total

Review 1.  Combinations of antifungal agents in therapy--what value are they?

Authors:  Manuel Cuenca-Estrella
Journal:  J Antimicrob Chemother       Date:  2004-09-16       Impact factor: 5.790

2.  In vitro susceptibility testing of Fonsecaea pedrosoi to antifungals.

Authors:  C de Bedout; B L Gómez; A Restrepo
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1997 May-Jun       Impact factor: 1.846

3.  In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.

Authors:  A Espinel-Ingroff
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

4.  In vitro evaluation of combination of terbinafine with itraconazole or amphotericin B against Zygomycota.

Authors:  Alicia Gómez-López; Manuel Cuenca-Estrella; Emilia Mellado; Juan L Rodríguez-Tudela
Journal:  Diagn Microbiol Infect Dis       Date:  2003-03       Impact factor: 2.803

5.  Successful treatment for chromoblastomycosis caused by Fonsecaea monophora: a report of three cases in Guangdong, China.

Authors:  Junmin Zhang; Liyan Xi; Changming Lu; Xiqing Li; Ting Xie; Hui Zhang; Zhi Xie; Sybren De Hoog
Journal:  Mycoses       Date:  2008-06-21       Impact factor: 4.377

6.  In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates.

Authors:  Joseph Meletiadis; Johan W Mouton; Jacques F G M Meis; Paul E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

Review 7.  Infections of the central nervous system by melanized fungi: a review of cases presented between 1999 and 2004.

Authors:  A S Kantarcioglu; G S de Hoog
Journal:  Mycoses       Date:  2004-02       Impact factor: 4.377

8.  Susceptibility of sequential Fonsecaea pedrosoi isolates from chromoblastomycosis patients to antifungal agents.

Authors:  Tânia S Andrade; Luiz G M Castro; Ricardo S Nunes; Viviane M F Gimenes; Arlete E Cury
Journal:  Mycoses       Date:  2004-06       Impact factor: 4.377

9.  In vitro interactions of approved and novel drugs against Paecilomyces spp.

Authors:  Montserrat Ortoneda; Javier Capilla; F Javier Pastor; Isabel Pujol; Clara Yustes; Carolina Serena; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

10.  In vitro testing of susceptibilities of filamentous ascomycetes to voriconazole, itraconazole, and amphotericin B, with consideration of phylogenetic implications.

Authors:  M R McGinnis; L Pasarell
Journal:  J Clin Microbiol       Date:  1998-08       Impact factor: 5.948

View more
  8 in total

1.  Terbinafine in combination with other antifungal agents for treatment of resistant or refractory mycoses: investigating optimal dosing regimens using a physiologically based pharmacokinetic model.

Authors:  Michael J Dolton; Vidya Perera; Lisa G Pont; Andrew J McLachlan
Journal:  Antimicrob Agents Chemother       Date:  2013-10-14       Impact factor: 5.191

2.  Drug combinations against Mucor irregularis in vitro.

Authors:  Shuzhen Zhang; Ruoyu Li; Jin Yu
Journal:  Antimicrob Agents Chemother       Date:  2013-04-15       Impact factor: 5.191

3.  In vitro activities of nine antifungal drugs and their combinations against Phialophora verrucosa.

Authors:  Yali Li; Zhe Wan; Ruoyu Li
Journal:  Antimicrob Agents Chemother       Date:  2014-06-30       Impact factor: 5.191

4.  In Vitro Antifungal Activities against Moulds Isolated from Dermatological Specimens.

Authors:  Tzar Mohd Nizam; Rabiatul Adawiyah Ag Binting; Shafika Mohd Saari; Thivyananthini Vijaya Kumar; Marianayati Muhammad; Hartini Satim; Hamidah Yusoff; Jacinta Santhanam
Journal:  Malays J Med Sci       Date:  2016-05

5.  In vitro susceptibility of environmental isolates of Exophiala dermatitidis to five antifungal drugs.

Authors:  Ana Paula Miranda Duarte; Fernando Carlos Pagnocca; Noemi Carla Baron; Marcia de Souza Carvalho Melhem; Gislene Aparecida Palmeira; Dejanira de Franceschi de Angelis; Derlene Attili-Angelis
Journal:  Mycopathologia       Date:  2012-11-16       Impact factor: 2.574

6.  Combination of Amphotericin B and Terbinafine against Melanized Fungi Associated with Chromoblastomycosis.

Authors:  S Deng; W Lei; G S de Hoog; L Yang; R G Vitale; H Rafati; M Seyedmousavi; A Tolooe; H van der Lee; W Liao; P E Verweij; S Seyedmousavi
Journal:  Antimicrob Agents Chemother       Date:  2018-05-25       Impact factor: 5.191

7.  New possibilities for chromoblastomycosis and phaeohyphomycosis treatment: identification of two compounds from the MMV Pathogen Box® that present synergism with itraconazole.

Authors:  Rowena Alves Coelho; Gabriela Machado Alves; Maria Helena Galdino Figueiredo-Carvalho; Fernando Almeida-Silva; Gabriela Rodrigues de Souza; Maria Cristina da Silva Lourenço; Fábio Brito-Santos; Ana Claudia Fernandes Amaral; Rodrigo Almeida-Paes
Journal:  Mem Inst Oswaldo Cruz       Date:  2022-09-12       Impact factor: 2.747

8.  Phaeoacremonium parasiticum phaeohyphomycosis in a patient with systemic lupus erythematosus treated successfully with surgical debridement and voriconazole: A case report and review of the literature.

Authors:  Rima I El-Herte; Katie E Schouweiler; Ronda S Farah; Ricardo Arbulu; Daniel Diekema; Karolyn A Wanat; Bradley A Ford
Journal:  IDCases       Date:  2014-10-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.